L2 Asset Management’s DexCom DXCM Stock Holding History

L2 Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,068	Closed	-$274K	–	372
2025 Q3	$274K	Buy	+4,068	New	+$322K	0.04%	301

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

L2 Asset Management's DXCM Position: Q4 2025 in Review

L2 Asset Management sold out of DexCom (DXCM) in Q4 2025, closing a stake of 4,068 shares — an estimated $274K sold.

L2 Asset Management first reported a position in DXCM in Q3 2025 and held it in 1 quarter. The position peaked at $274K in Q3 2025. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

L2 Asset Management reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
L2 Asset Management sold 4,068 DexCom shares in Q4 2025, an estimated $274K.
L2 Asset Management first reported a position in DexCom in Q3 2025 and held it in 1 quarter.
L2 Asset Management's DexCom position peaked at $274K in Q3 2025.
922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on L2 Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.